Manifestation of Novel Social Challenges of the European Union in the Teaching Material of Medical Biotechnology Master’s Programmes at the University.

Slides:



Advertisements
Similar presentations
Signal Transduction Mechanisms Underlying Underlying Growth Control and Oncogenesis Ronit Sagi-Eisenberg Dept. of Cell and Developmental Biology Sackler.
Advertisements

Medical Biochemistry Membranes: Membrane receptors; G-proteins Lecture 73 Membranes: Membrane receptors; G-proteins Lecture 73.
Coordination of cellular-fate processes
Cell communication Chapter 9 Genes and Development.
Chapter 15: Signal transduction Know the terminology: Enzyme-linked receptor, G-protein linked receptor, nuclear hormone receptor, G-protein, adaptor protein,
Structural Basis for Ligand- Receptor Recognition and Dimerization Moosa Mohammadi Dept. of Pharmacology Medical Science Building, 4th Floor, Rooms 425,
Lecture 11: Signalling for Life/Death 1)Describe the eukaryotic cell cycle and the purpose of checkpoints. 2)Describe the role of cyclins and cyclin-dependent.
Manifestation of Novel Social Challenges of the European Union in the Teaching Material of Medical Biotechnology Master’s Programmes at the University.
Mechanisms of action of peptide hormones Raymond B. Birge, PhD Lecture 27- Birge.
Enzyme-linked Cell Surface Receptors 16 April 2007.
Lecture 23 Signal Transduction 2
Chap. 16 Signaling Pathways That Control Gene Expression
Ligand Receptor Cortisol Receptor is located in the cytosol Retinoid Receptors are in the nucleus Target gene in the nucleus Regulation of Transcription.
Manifestation of Novel Social Challenges of the European Union in the Teaching Material of Medical Biotechnology Master’s Programmes at the University.
Manifestation of Novel Social Challenges of the European Union in the Teaching Material of Medical Biotechnology Master’s Programmes at the University.
Manifestation of Novel Social Challenges of the European Union in the Teaching Material of Medical Biotechnology Master’s Programmes at the University.
Manifestation of Novel Social Challenges of the European Union in the Teaching Material of Medical Biotechnology Master’s Programmes at the University.
Chapter 20 oncogene, anti-oncogene and growth factor The biochemistry and molecular biology department of CMU.
Manifestation of Novel Social Challenges of the European Union in the Teaching Material of Medical Biotechnology Master’s Programmes at the University.
Lecture 9: Cell signaling Dr. Mamoun Ahram Faculty of Medicine Second year, Second semester, Principles of Genetics and Molecular Biology.
Cell Signaling Lecture 9
Manifestation of Novel Social Challenges of the European Union in the Teaching Material of Medical Biotechnology Master’s Programmes at the University.
Growth Factors, Receptors, and Signal Transduction I
Signal Transduction II Transduction Proteins & Second Messengers.
BIOL 5190/6190 Cellular & Molecular Singal Transduction
Cytoplasmic Signaling Circuitry Programs Many of the Traits of Cancer
Manifestation of Novel Social Challenges of the European Union in the Teaching Material of Medical Biotechnology Master’s Programmes at the University.
Student Research Interest HER2 Receptor Signaling in Breast Cancer Cells Marc Y. Fink Biomedical Sciences LIU-Post.
Signal Transduction Biochemistry – February 23, 2005 Chapter 12 – parts 12.3, 12.4.
CGMP Intracellular Signal cGMP is made from GTP by the enzyme gaunylyl cyclase. Atrial natriuretic peptide and nitric oxide function through this Signal.
1 Dr. Karen Schmeichel January 22, 2009 BIO 290 Special Topics in Biology: Cancer Biology Lecture #4 “Profile of a Cancer Cell”
Manifestation of Novel Social Challenges of the European Union in the Teaching Material of Medical Biotechnology Master’s Programmes at the University.
Gene Transcription G0G0 G1G1 Priming S G2G2 M Cell Cell Cycle Growth Factors + Growth Factors & Cell Cycle Receptors.
Manifestation of Novel Social Challenges of the European Union in the Teaching Material of Medical Biotechnology Master’s Programmes at the University.
CZ5225: Modeling and Simulation in Biology Lecture 10: Biological Pathways II: Signaling Pathways Prof. Chen Yu Zong Tel:
Manifestation of Novel Social Challenges of the European Union in the Teaching Material of Medical Biotechnology Master’s Programmes at the University.
CDCA7 A case study in cellular regulation
Cell Signaling II Signal Transduction pathways
Protein Domains That Interact with Receptor Tyrosine Kinases: Structural Aspects Ming-Ming Zhou, Ph.D. MSSM Department of Pharmacology Course on “Cell.
Advanced Bioinformatics Lecture 5: Signal transduction and simulation ZHU FENG Innovative Drug Research Centre.
oncogene, anti-oncogene and growth factor
1 Hepatocellular Carcinoma Overview of Hepatocellular Carcinoma Epidemiology.
Signal Transduction I Receptors & Ligands. Signal Transduction.
How to present a scientific paper Dr. Rebecca B. Riggins Department of Oncology, Georgetown University
Chapter 14. Signal Transduction Signal transduction is the process by which an extracellular signal alters intracellular events. 1. First and second messengers.
Chapter 15 Cellular Signal Transduction The biochemistry and molecular biology department of CMU.
Ion channels as targets for G-proteins G-protein-coupled receptors can control ion channel function directly by mechanisms that do not involve second messengers.
Chapter 15- Cell Communication Part I- General signaling strategies
Signal transduction: receptor gene
Negative regulation of cell cycle by intracellular signals Checkpoint p53 detects DNA damage & activates p21 p21 inhibits cdk2-cyclinA Intracellular Regulation.
An Introduction to Medicinal Chemistry 3/e PROTEINS AS DRUG TARGETS:
An Introduction to Medicinal Chemistry 3/e PROTEINS AS DRUG TARGETS:
Lung Cancer Tumour Markers
Growth factors Polypeptides in nature
Intercellular Communication
Eph-Ephrin Bidirectional Signaling in Physiology and Disease
Sustaining Proliferative Signaling and Evading Growth Suppressors
Underlying Mechanisms for Distant Metastasis - Molecular Biology
Signal Transduction Through the Epidermal Growth Factor Receptor
Cell Signaling by Receptor Tyrosine Kinases
BDNF and insulin signaling pathways activated by phytochemicals.
Development of PI3K/AKT/mTOR Pathway Inhibitors and Their Application in Personalized Therapy for Non–Small-Cell Lung Cancer  Vassiliki Papadimitrakopoulou,
Bhagelu Ram Achyut, Li Yang  Gastroenterology 
Vascular Endothelial Growth Factor and Epidermal Growth Factor Signaling Pathways as Therapeutic Targets for Colorectal Cancer  Thomas Winder, Heinz–Josef.
Signal Transduction Through the Epidermal Growth Factor Receptor
Yan Feng, MD, Praveena S. Thiagarajan, PhD, Patrick C. Ma, MD 
Platelet-derived growth factor (PDGF) signalling pathway.
Brief Review – Growth Factors and Receptors
Cell Signaling by Receptor Tyrosine Kinases
Presentation transcript:

Manifestation of Novel Social Challenges of the European Union in the Teaching Material of Medical Biotechnology Master’s Programmes at the University of Pécs and at the University of Debrecen Identification number: TÁMOP /1/A

TYROSINE KINASE- LINKED RECEPTORS PART 2 GROWTH FACTORS Tímea Berki and Ferenc Boldizsár Signal transduction Manifestation of Novel Social Challenges of the European Union in the Teaching Material of Medical Biotechnology Master’s Programmes at the University of Pécs and at the University of Debrecen Identification number: TÁMOP /1/A

TÁMOP /1/A Growth factors (GFs) Small molecular weight soluble mediators They control: 1 1Proliferation 2 2Survival 3 3Metabolism 4 4Tissue differentiation Important implication in tumors Cytokines – growth factors

TÁMOP /1/A Growth factors (GFs) – History How to propagate cells under in vitro conditions (turning of the 19 th -20 th century)? Rous: experiments with chicken tumor (sarcoma) cells (RSV) Carrel: In simple buffered salt solution the cells did not proliferate – trials with diluted plasma/serum Temin and Dulbecco: precise requirements for tissue culturing: –Reduced serum need of tumor cells – enhanced capacity of tumor cells to respond to proliferation signals –Serum supported cell growth rather than plasma – PDGF Rita Levi-Montalcini, Stanley Cohen – NGF and EGF Transplantation of an actively growing mouse tumor into chicken induced the great amplification of nerve fibres into the tumor mass

TÁMOP /1/A Growth factors FactorPrincipal sourcePrimal activityComments PDGF Platelets, endothelial cells, placenta Promotes proliferation of connective tissue, glial and smooth muscle cells Two differentprotein chains from 3 distinct dimer forms; AA, AB and BB EGF Submaxillary gland, Brunners gland Promotes proliferation of mesenchymal, glial and epithelial cells TGF-αCommon in transformed cells May be important for normal wound healing Related to EGF FGF Wide range of cells; protein is associated with the ECM Promotes proliferation of many cells; inhibits some stem cells; induces mesoderm to form in early embrios At least 18 family members, 5 distinct receptors NGF Mast cells, eosinophils, bone marrow stromal cells, keratinocytes Promotes neurite outgrowth and neural cell survival Member of a family of proteins termed neutrophins that promote proliferation and survival of neurons; neutrophin receptors are a class of related proteins first identified as proto-oncogenes? TrkA („trackA”), TrkB, TrkC ErythropoietinKidneyPromotes proliferation of erythrocytes TGF-β Activated Th1 cells (T-helper) and natural killer (NK) cells Anti-inflammatory (suppresses cytokine production and class II MHC expression), promotes wound healing, inhibits macrophage and lymphocyte proliferation At least 100 different family members IGF-1Primarily liverPromotes proliferation of many cell types Related to IGF-2 and proinsulin, also called somatomedin C IGF-2Variety of cells Promotes proliferation of many cell types primarily of fetal origin Related to IGF-1 and proinsulin

TÁMOP /1/A Receptors with TK activity Receptor Tyrosine Kinases (RTK) e.g. PDGF, insulin, EGF, VEGF and FGF receptors Tyrosine-Kinase Associated Receptors Receptors that associate with proteins that have tyrosine kinase activity (Cytokine Receptors) Receptor Tyrosine Phosphatases e.g. CD45 protein of T cells and macrophages

TÁMOP /1/A “Complete” and “incomplete” receptor tyrosine kinase “Complete” receptor tyrosine kinase “Incomplete” receptor Cytoplasmic non-receptor tyrosine kinase Adaptor SignalSignal

TÁMOP /1/A Receptor tyrosine kinase (RTK) families 90 unique Tyr kinases in the human genome, 58 are RTKs Growth factor, cytokine and hormone receptors Classes: I EGFR family (ErbB) XLTK family II Insulin rec. family XITIE family IIIPDGF familyXIIROR family IVFGF familyXIIIDDR family VVEGF familyXIVRET family VI HGF family (c- Met) XVKLG family VIITrk familyXVIRYK family VIIIEph familyXVIIMuSK family IXAXL family

TÁMOP /1/A Kinase-phosphatase balance Phosphorylase kinase (ser/thr kinase) PP1c (ser/thr phosphatase) Phosphorylase b Phosphorylase a P P InactiveActive P ATPADP CD45 (tyr phosphatase) Csk (tyr kinase) ADPATP Inactive p56 Lck P Y505 Y394 Primed p56 Lck Y505 Y394 Active p56 Lck P Y394 P

TÁMOP /1/A Fibronectin III Leucine-rich Cysteine-rich Acid-box Kinase IG-like VEGFR1 VEGFR2 VEGFR3 PDGFR  PDGFR β CSF1R Kit Kit2 RykTorsoEGFR ErbB2 ErbB3 ErbB4 Met Ron Sea TrkA TrkB TrkC INSR IGF1R IRR Axl Mer Sky Eph Eck Eek Erk Elk Ehk1 Ehk2 Sek Hek Hek11 Cek-9 Myk-1 Myk-2 RosFGFR1 FGFR2 FGFR3 FGFR4 Tie Tie2 DDRRetTorpedoRor1 Ror2 Ltk Alk EGF-like Cadherin Factor VIII-like Glicyne-richKringle C1r-like Growth factor receptors

TÁMOP /1/A Receptor-like PTPs (21) CD45 (RC) R1/R6 PTP  (RM) PTP  (RK) PTP  (RT) PTP (RU) R2B LAR (RF) PYP  (RS) PTP  (RD) R2A PTP  (RA) PYP  (RE) R4 PTP  (RG) PYP  (RZ1) R5 PTP β (RB) DEP1 (RJ) SAP1 (RH) GLEPP1 (RO) PTPS31 (RP) R3 PCPTP1  (RR) STEP (N5) R7 IA2 (RN) IA2 β (RN2) R8 RGDS motif Proline-richMAM domain SEC14 domainFibronectin III FERM domain IG-like BRO-1 homologyGlycosylated PDZ domainCadherine-like Histidine domainCarbonic anhydrase-like Kinase-interacting domainPTP domain Src homology 2 PTP pseudo-phosphatase domain

TÁMOP /1/A Nontransmembrane PTPs (17) HDPTP (N23) NT8 MEG2 (N9)NT3 HePTP (N7) PTPH1 (N3) MEG1 (N14)NT5 SHP1 (N6) SHP2 (N11)NT2 PTPBAS (N13) NT7 PTPD1 (N21) PTPD2 β (142) NT6 PTP1B (N1) TCPTP β (N2)NT1 BDP1 (N18) PTP-PEST (N12) LYP (N220)NT4 PTPTyP (N20) NT9 RGDS motif Proline-richMAM domain SEC14 domainFibronectin III FERM domain IG-like BRO-1 homologyGlycosylated PDZ domainCadherine-like Histidine domainCarbonic anhydrase-like Kinase-interacting domainPTP domain Src homology 2 PTP pseudo-phosphatase domain

TÁMOP /1/A Growth factor receptors and tyrosine phosphorylation p120 Ras-Gap p120 Ras-Gap PLC  Phosphotyrosine Y559 Y581 Y716 Y741 Y751 Y771 Y1009 Y1021Phosphotyrosine Y992 Y1045 Y1068 Y1086 Y1148 Y1173 PDGFR P P P P P P P P P P P P P P EGFR P P P P P P P P P P

TÁMOP /1/A Receptor tyrosine kinase (RTK) signalingTranscription RTK Ligand P P P P P P P P Dimerization Src PKC PLC STAT JAK Akt

TÁMOP /1/A I GF receptor signaling pathways I Targets PIP 2 PIP 3 Targets Akt PDK1 PIP 3 SOS Ras Targets Erk Targets GRB2 Shp2 GRB2 PI3K RTK Ligand PP P P P P P P P Plasma membrane P P P P P P P P

TÁMOP /1/A II GF receptor signaling pathways IIRTK Ligand PIP 2 Cbl P PLC C2PHSH3SH2 Plasma membrane Cytoplasm P P P P P P P P

TÁMOP /1/A Overview of EGF signaling

TÁMOP /1/A General characteristics of GF signaling Diverse input signals (Multiple RTKs) Diverse input signals (Multiple RTKs) Conserved core processes Conserved core processes Diverse ouput events (transcriptional responses, cytokeletal changes, etc) Diverse ouput events (transcriptional responses, cytokeletal changes, etc) System control Input layer Output layer

TÁMOP /1/A Different GF receptors use the same signaling pathways PDGF-C Cell survival Proliferation Apoptosis resistance Metastasis Angiogenesis P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P EGFRHer2Her3Her4VEGFR1VEGFR2VEGFR3PDGFR-aPDGFR-bc-kit EGF TGF  β-cellulin Amphiregulin HB-EGF No specific ligands Heregulins β-cellulin NRG2 NRG3 VEGF-BVEGF-AVEGF-CVEGF-DPDGF-A PDGF-B PDGF-D SCF SOS GRB2 Ras Rac Rho CDC42 MEK1/2 Erk Raf ERK pathway MKK4/7 JNK MEKK JNK pathway MKK3/6 p38 Tak p38 pathway Akt mTor PI3K Everolimus Imatinib Trastuzumab Leflunomide Lapatinib Gefitinib Erlotinib Panitumumab Sorafenib Cetuximab Bevacizumab Vandetanib Sunitinib Enzastaurin Pazopanib Motesanib Midostaurin Temsirolimus Sirolimus P P P P P P P P

TÁMOP /1/A Natriuretic peptide signaling ↑NP degradation ↓cAMP? ↑ IP3? ↑ Vasorelaxation ↑ Diuresis, natriuresis ↓ Renin, aldosterone ↓ Cell proliferation ↓ Cardiac fibrosis ↑ Vasorelaxation ↓ Cell proliferation ↑ Long bone gowth Kinase homology domain Plasma membrane Ligand binding domain Receptor Hinge region Guanylyl cyclase domain Physiologic response Natriuretic peptide NPR-CNPR-A (GC-A) NPR-B (GC-B) ANPBNPCNPcGMPGTPcGMPGTP P P P P P P P P P P P P P P P P P P P P P P Natriuretic peptide Hormone bound Active Desensitised Kinase Phosphatase ATP cGMPGTP PP P PP PP Basal ATP